This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
The Zacks Analyst Blog Highlights: PayPal, International Business Machines, Fresenius Medical Care, Laboratory Corp. of America and Insulet
by Zacks Equity Research
The Zacks Analyst Blog Highlights: PayPal, International Business Machines, Fresenius Medical Care, Laboratory Corp. of America and Insulet
Dominion, Michaels, International Business Machines, Alphabet and Microsoft highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Dominion, Michaels, International Business Machines, Alphabet and Microsoft highlighted as Zacks Bull and Bear of the Day
Forget Slump, Buy Tech ETFs That Offer Value
by Sanghamitra Saha
Tech sector takes a hit from Trump's immigration ban plan and overvaluation concerns.
Top Stock Reports for PayPal, IBM & Fresenius Medical
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including PayPal (PYPL), International Business Machines (IBM) and Fresenius Medical Care (FMS).
Verizon Q1 Earnings Preview: Buy VZ Stock for Stability Amid Coronavirus?
by Benjamin Rains
Let's dive into what's going with Verizon to help investors see if they should consider buying VZ stock with its Q1 earnings due out Friday morning...
IBM Withdraws 2020 Guidance, What to Do with the Shares?
by Sejuti Banerjea
The new CEO will play an important role in turning the company around, but should you hang in there and cash out is the question.
IBM Reports Mixed Q1 Results: ETFs in Focus
by Sweta Killa
IBM beat earnings estimates but lagged on revenues. It withdrew its full-year guidance citing uncertainty surrounding the COVID-19 pandemic.
IBM Beats on Q1 Earnings, Withdraws '20 View on Coronavirus Woes
by Zacks Equity Research
IBM's first-quarter results reflect solid growth in Cloud revenues. However, coronavirus outbreak impacted adoption of cognitive applications and transaction processing platforms in March.
IBM to Report Q1 Earnings After Market Close: ETFs in Focus
by Sweta Killa
IBM has seen positive earnings estimate revision of a penny for the first quarter over the last seven days. Analysts increasing estimates right before earnings - with the most up-to-date information possible - is a good indicator for the stock.
Markets Dragged by Crude Oil Futures
by Zacks Equity Research
Markets Dragged by Crude Oil Futures
Crude Oil Futures Plummet, Taking Markets Down
by Mark Vickery
WTI futures for May are down 36% -- just today -- to below $12 per barrel. Brent May futures are down 6%.
The Zacks Analyst Blog Highlights: IBM and Microsoft
by Zacks Equity Research
The Zacks Analyst Blog Highlights: IBM and Microsoft
Netflix, IBM, Intel and Southwest are part of Zacks Earnings Preview
by Zacks Equity Research
Netflix, IBM, Intel and Southwest are part of Zacks Earnings Preview
Buy IBM Stock Ahead of Q1 2020 Earnings?
by Benjamin Rains
IBM is set to report its Q1 fiscal 2020 results on Monday, April 20. The historic tech power hopes to emulate the likes of Microsoft as it transitions deeper into cloud computing. The question is should investors consider buying IBM stock?
Microsoft (MSFT) Partners With NBA to Enhance Fan Experience
by Zacks Equity Research
Microsoft (MSFT) teams up with NBA to personalize online experiences for fans and generate deeper game insights for coaches as well as officials.
Is the Market Ahead of Itself?
by Sheraz Mian
The numbers will get bad in the current period (2020 Q2), really bad, before they start getting better...
CACI Wins $83M Task Order to Support Portsmouth Naval Shipyard
by Zacks Equity Research
CACI International (CACI) wins a contract worth $83 million, per which it will provide planning, operations and maintenance support to the U.S. Navy.
Factors to Watch as IBM Gears Up to Report Q1 Earnings
by Zacks Equity Research
International Business Machines (IBM) Q1 results are likely to reflect solid adoption of hybrid cloud, Watson, and blockchain platforms. However, competition in cloud market remains a headwind.
What's in Store for Dow ETFs in Q1 Earnings?
by Sweta Killa
With most blue-chip companies' earnings scheduled over the coming weeks, investors should closely monitor the movement of the Dow ETF.
IBM (IBM) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, IBM (IBM) closed at $121.50, marking a +1.85% move from the previous day.
Should We Be Concerned About Apple In 2020?
by Sejuti Banerjea
AAPL remains a stock I'd hang on to.
The Zacks Analyst Blog Highlights: Johnson & Johnson, Merck & Co, Novartis, PayPal and IBM
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Johnson & Johnson, Merck & Co, Novartis, PayPal and IBM
IBM's Cloud Selected by Movius to Provide Improved Services
by Zacks Equity Research
IBM's (IBM) public cloud services witness robust traction driven by the digital transformation taking place in the industry.
Top Stock Reports for J&J, Merck, Novartis & Others
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson (JNJ), Merck (MRK) and Novartis (NVS).
ETFs to Gain on Cloud Computing Growth Amid Coronavirus Crisis
by Sweta Jaiswal, FRM
Cloud computing comes to the rescue as countries practice social distancing, making people work remotely to contain the coronavirus outbreak.